W
GMAB icon

WealthCollab’s Genmab GMAB Stock Holding History

WealthCollab’s Portfolio GMAB Stock Details GMAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$9.81K Hold
357
– – ﹤0.01% 577
2026
Q1 		$9.58K Hold
357
– – ﹤0.01% 559
2025
Q4 		$11K Hold
357
– – ﹤0.01% 542
2025
Q3 		$10.9K Hold
357
– – 0.01% 507
2025
Q2 		$7.38K Sell
357
-170
-32% -$3.49K ﹤0.01% 558
2025
Q1 		$10.3K Hold
527
– – 0.01% 462
2024
Q4 		$11K Sell
527
-147
-22% -$3.23K 0.01% 423
2024
Q3 		$16.4K Buy
674
+383
+132% +$10.2K 0.01% 361
2024
Q2 		$7.31K Buy
+291
New +$8.25K 0.01% 493

Other funds holding GMAB

PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

WealthCollab's GMAB Position: Q2 2026 in Review

WealthCollab held its Genmab (GMAB) position steady in Q2 2026 at 357 shares worth $9.81K. The position accounts for ﹤0.01% of the portfolio, ranked #577.

WealthCollab first reported a position in GMAB in Q2 2024 and has held it in 9 quarters since. The position peaked at $16.4K in Q3 2024. 290 funds tracked by Wall St. Rank hold GMAB as of Q2 2026.

  • WealthCollab held 357 shares of Genmab worth $9.81K as of Q2 2026.
  • WealthCollab left its Genmab share count unchanged in Q2 2026.
  • Genmab made up ﹤0.01% of WealthCollab's portfolio in Q2 2026, its #577 holding.
  • WealthCollab first reported a position in Genmab in Q2 2024 and has held it in 9 quarters since.
  • WealthCollab's Genmab position peaked at $16.4K in Q3 2024.
  • 290 funds tracked by Wall St. Rank held Genmab as of Q2 2026.

Based on WealthCollab's 13F filing for Q2 2026, filed 10 Aug 2026.